IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 372 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $28,447,917 | +24.3% | 627,159 | +12.4% | 0.01% | +20.0% |
Q2 2023 | $22,884,647 | +13.1% | 557,754 | -1.5% | 0.01% | +25.0% |
Q1 2023 | $20,232,234 | -6.6% | 566,095 | -1.3% | 0.00% | -20.0% |
Q4 2022 | $21,672,351 | -15.4% | 573,798 | -1.0% | 0.01% | -16.7% |
Q3 2022 | $25,629,000 | +4.1% | 579,413 | -12.9% | 0.01% | 0.0% |
Q2 2022 | $24,630,000 | +21.1% | 665,316 | +21.1% | 0.01% | +50.0% |
Q1 2022 | $20,346,000 | +20.1% | 549,247 | -1.3% | 0.00% | +33.3% |
Q4 2021 | $16,937,000 | -9.9% | 556,577 | -0.7% | 0.00% | -25.0% |
Q3 2021 | $18,801,000 | -12.8% | 560,566 | +3.7% | 0.00% | 0.0% |
Q2 2021 | $21,562,000 | -12.0% | 540,529 | -0.8% | 0.00% | -20.0% |
Q1 2021 | $24,507,000 | -24.0% | 545,098 | -4.4% | 0.01% | -28.6% |
Q4 2020 | $32,227,000 | +24.1% | 569,994 | +4.1% | 0.01% | +16.7% |
Q3 2020 | $25,972,000 | -20.6% | 547,356 | -1.4% | 0.01% | -33.3% |
Q2 2020 | $32,726,000 | +25.0% | 555,061 | +0.2% | 0.01% | 0.0% |
Q1 2020 | $26,191,000 | -24.4% | 553,970 | -3.5% | 0.01% | 0.0% |
Q4 2019 | $34,661,000 | +5.7% | 573,774 | +4.8% | 0.01% | 0.0% |
Q3 2019 | $32,786,000 | -6.5% | 547,235 | +0.3% | 0.01% | -10.0% |
Q2 2019 | $35,055,000 | -16.8% | 545,435 | +5.1% | 0.01% | -16.7% |
Q1 2019 | $42,131,000 | +47.0% | 519,057 | -2.1% | 0.01% | +33.3% |
Q4 2018 | $28,667,000 | +5.3% | 530,282 | +0.5% | 0.01% | +28.6% |
Q3 2018 | $27,229,000 | +25.9% | 527,902 | +1.7% | 0.01% | +16.7% |
Q2 2018 | $21,634,000 | -9.5% | 519,161 | -4.3% | 0.01% | -14.3% |
Q1 2018 | $23,902,000 | -12.1% | 542,247 | +0.3% | 0.01% | 0.0% |
Q4 2017 | $27,206,000 | -0.5% | 540,877 | +0.3% | 0.01% | -12.5% |
Q3 2017 | $27,349,000 | +1.8% | 539,447 | +2.2% | 0.01% | 0.0% |
Q2 2017 | $26,859,000 | +26.1% | 528,000 | -0.3% | 0.01% | +33.3% |
Q1 2017 | $21,292,000 | -14.2% | 529,657 | +2.1% | 0.01% | -14.3% |
Q4 2016 | $24,809,000 | +38.8% | 518,690 | +6.3% | 0.01% | +40.0% |
Q3 2016 | $17,875,000 | +36.6% | 487,869 | -13.2% | 0.01% | +25.0% |
Q2 2016 | $13,085,000 | -42.8% | 561,835 | -0.6% | 0.00% | -42.9% |
Q1 2016 | $22,890,000 | -33.9% | 565,171 | +1.1% | 0.01% | -30.0% |
Q4 2015 | $34,618,000 | – | 559,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |